DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program
Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue. January 24, 2024 11:01 AM Eastern Standard Time COLUMBUS, Ohio–(BUSINESS WIRE)–DNA Nanobots, a leader in the design and…